Variant · Snv
LRBA NM_001364905.1(LRBA):c.6781-3C>T
CI-VAR-00073752Explore in graph →NM_001364905.1:c.6781-3C>TClinVar 473183 rs58873298
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 473183 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Combined immunodeficiency due to LRBA deficiency; Uterine corpus endometrial carcinoma; Gastric cancer; Acute myeloid leukemia; Malignant tumor of esophagus; Ovarian serous cystadenocarcinoma; Hepatocellular carcinoma | germline | 7 | Feb 02, 2026 | clinvar |